← Back to headlines
argenx Invests $2.2 Billion in Vitiligo Breakthrough with Forte Biosciences Deal
argenx has committed $2.2 billion to a vitiligo breakthrough through a deal with Forte Biosciences, with implications for both companies' stock performance.
29 Jul, 07:45 — 29 Jul, 07:45
Sources
Showing 1 of 1 sources
